Deutsche Bank Ag\ Oyster Point Pharma, Inc. Transaction History

Deutsche Bank Ag\

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$3.6 - $11.2 $22,327 - $69,462	-6,202 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.58 - $17.65 $6,177 - $12,707	-720 Reduced 10.4%	6,202 $72,000
Q4 2021 Feb 11, 2022	BUY	$10.17 - $18.96 $3,661 - $6,825	360 Added 5.49%	6,922 $126,000
Q3 2021 Nov 04, 2021	SELL	$11.67 - $18.07 $2,334 - $3,614	-200 Reduced 2.96%	6,562 $78,000
Q2 2021 Aug 11, 2021	BUY	$16.25 - $21.51 $45,175 - $59,797	2,780 Added 69.81%	6,762 $116,000
Q1 2021 May 13, 2021	SELL	$17.92 - $25.86 $9,031 - $13,033	-504 Reduced 11.23%	3,982 $72,000
Q4 2020 Feb 16, 2021	BUY	$18.13 - $25.18 $23,260 - $32,305	1,283 Added 40.06%	4,486 $84,000
Q3 2020 Nov 12, 2020	BUY	$17.83 - $29.12 $12,908 - $21,082	724 Added 29.21%	3,203 $68,000
Q2 2020 Aug 13, 2020	BUY	$27.86 - $35.93 $15,100 - $19,474	542 Added 27.98%	2,479 $72,000
Q1 2020 May 14, 2020	BUY	$23.65 - $40.96 $1,229 - $2,129	52 Added 2.76%	1,937 $68,000
Q4 2019 Feb 14, 2020	BUY	$13.55 - $26.15 $25,541 - $49,292	1,885 New	1,885 $46,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.